Why Respiratory Health?
Our respiratory health portfolio isn't a pivot — it's personal. Aaran's doctoral research into COPD gave us a clinician-level understanding of how people with chronic lung conditions interact with their devices every day — the daily frustrations, the workarounds, the unmet needs that the market hasn't yet resolved. Every product in our respiratory range starts from that lived research reality, not from a gap-spotting exercise.
But the deeper we went, the more clearly we saw the same pattern repeating across other categories. People managing mobility challenges, athletes absorbing stress through their hands, anyone navigating a healthcare touchpoint that hasn't kept pace with what's possible. The unmet needs weren't unique to respiratory health — they were everywhere that product design had stalled and clinical insight hadn't yet arrived.
So we kept going.
Wellvibes now develops IP across respiratory health, active grip and mobility, and wellness — each product category built on the same foundation: research-led insight, production-ready specification, and a clear commercial case for the right licensing partner.
The Market Opportunity — Respiratory Health
Over 500 million people worldwide live with a chronic respiratory condition requiring inhaler therapy — including asthma, COPD, bronchitis, and cystic fibrosis. That's a patient population larger than the entire population of the European Union, managing their condition every day, in every pharmacy market in the world.
Despite this scale, the MDI and DPI accessory category remains largely underdeveloped in mainstream pharmacy retail. The devices themselves are well-established. The clinical support infrastructure around them — the accessories, the compliance tools, the everyday management products that make inhaler therapy easier, safer, and more consistent — represents a significant and largely untapped shelf opportunity.
Wellvibes is developing the products to fill that gap.
The Market Opportunity — Active Grip & Mobility
Over 1.85 billion people worldwide live with a musculoskeletal condition affecting their movement or grip — and hundreds of millions more use mobility aids, sporting equipment, or rehabilitation tools every day. Yet the handle and grip accessory category has seen almost no material innovation in decades.
Wellvibes is developing IP to change that.
Grounded in Science, Built for the Shelf
The difference between a product that sits in a lab and one that earns its place on a pharmacy shelf comes down to three things: clinical credibility, consumer relevance, and commercial viability. Every product Wellvibes develops is built against all three.
Our respiratory portfolio draws directly on Aaran's PhD-level research into COPD and respiratory disease management. That scientific foundation shapes not just the product design but the evidence package we bring to licensing conversations — giving pharmacy buyers and their regulatory teams the confidence that what they're ranging has real clinical backing, not just consumer appeal.
The same discipline applies across our broader portfolio. We don't develop products because they're clever. We develop them because the gap is real, the consumer need is demonstrable, and the commercial case for a licensee is clear.
From Concept to Production-Ready
Wellvibes works with an established network of ISO 13485-certified contract manufacturers across Asia and Europe, with existing relationships covering LSR moulding, precision injection moulding, and medical-grade assembly. Every product is developed to a full production-ready specification including bill of materials, tooling brief, and a CM-ready engineering package — so that when the right licensing partner is identified, the path from agreement to shelf is as short as possible.
Details about our products are available under NDA.
